🇺🇸 Vesanoid in United States
308 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 308
Most-reported reactions
- Retinoic Acid Syndrome — 55 reports (17.86%)
- Pyrexia — 47 reports (15.26%)
- Electrocardiogram Qt Prolonged — 32 reports (10.39%)
- Headache — 32 reports (10.39%)
- Differentiation Syndrome — 31 reports (10.06%)
- Hyperleukocytosis — 25 reports (8.12%)
- Diarrhoea — 22 reports (7.14%)
- Hypomagnesaemia — 22 reports (7.14%)
- Disseminated Intravascular Coagulation — 21 reports (6.82%)
- Hypokalaemia — 21 reports (6.82%)
Other Other approved in United States
Frequently asked questions
Is Vesanoid approved in United States?
Vesanoid does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Vesanoid in United States?
Centre Leon Berard is the originator. The local marketing authorisation holder may differ — check the official source linked above.